Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...
Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...
Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.
An update from Masimo ( (MASI) ) is now available. Masimo Corporation reported strong financial results for Q3 2024, with consolidated revenue ...
Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago. These figures are ...
Masimo Corp. (MASI) on Tuesday reported third-quarter earnings of $9.8 million. On a per-share basis, the Irvine, California-based company said it had ...
Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $5,655.84 today based on a price of $144.22 for MASI at the time of writing.
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...